South Korea · Delayed Price · Currency is KRW Prestige BioPharma Statistics
Total Valuation
KRX:950210 has a market cap or net worth of KRW 79.21 billion. The enterprise value is 183.47 billion.
| Market Cap | 79.21B |
| Enterprise Value | 183.47B |
Important Dates
The next estimated earnings date is Friday, September 18, 2026.
| Earnings Date | Sep 18, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
KRX:950210 has 12.02 million shares outstanding. The number of shares has increased by 0.06% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 12.02M |
| Shares Change (YoY) | +0.06% |
| Shares Change (QoQ) | +0.88% |
| Owned by Insiders (%) | 30.40% |
| Owned by Institutions (%) | 0.11% |
| Float | 3.59M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.89 |
| PB Ratio | 0.14 |
| P/TBV Ratio | 0.19 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 11.32 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.85, with a Debt / Equity ratio of 0.16.
| Current Ratio | 0.85 |
| Quick Ratio | 0.53 |
| Debt / Equity | 0.16 |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.54 |
| Interest Coverage | -11.00 |
Financial Efficiency
Return on equity (ROE) is -14.54% and return on invested capital (ROIC) is -15.77%.
| Return on Equity (ROE) | -14.54% |
| Return on Assets (ROA) | -6.72% |
| Return on Invested Capital (ROIC) | -15.77% |
| Return on Capital Employed (ROCE) | -13.08% |
| Weighted Average Cost of Capital (WACC) | 6.68% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | 65 |
| Asset Turnover | 0.02 |
| Inventory Turnover | 1.11 |
Taxes
| Income Tax | -338.05M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -44.85% in the last 52 weeks. The beta is 0.42, so KRX:950210's price volatility has been lower than the market average.
| Beta (5Y) | 0.42 |
| 52-Week Price Change | -44.85% |
| 50-Day Moving Average | 7,996.20 |
| 200-Day Moving Average | 11,227.25 |
| Relative Strength Index (RSI) | 38.87 |
| Average Volume (20 Days) | 90,713 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KRX:950210 had revenue of KRW 16.21 billion and -57.32 billion in losses. Loss per share was -953.45.
| Revenue | 16.21B |
| Gross Profit | -16.08B |
| Operating Income | -83.87B |
| Pretax Income | -80.01B |
| Net Income | -57.32B |
| EBITDA | -57.92B |
| EBIT | -83.87B |
| Loss Per Share | -953.45 |
Balance Sheet
The company has 65.89 billion in cash and 88.81 billion in debt, with a net cash position of -22.92 billion or -1,906.72 per share.
| Cash & Cash Equivalents | 65.89B |
| Total Debt | 88.81B |
| Net Cash | -22.92B |
| Net Cash Per Share | -1,906.72 |
| Equity (Book Value) | 554.68B |
| Book Value Per Share | 7,845.71 |
| Working Capital | -18.67B |
Cash Flow
In the last 12 months, operating cash flow was -41.21 billion and capital expenditures -16.32 billion, giving a free cash flow of -57.53 billion.
| Operating Cash Flow | -41.21B |
| Capital Expenditures | -16.32B |
| Depreciation & Amortization | 25.95B |
| Net Borrowing | -69.15B |
| Free Cash Flow | -57.53B |
| FCF Per Share | -4,786.88 |
Margins
| Gross Margin | -99.22% |
| Operating Margin | -517.38% |
| Pretax Margin | -493.59% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
KRX:950210 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.06% |
| Shareholder Yield | -0.06% |
| Earnings Yield | -72.37% |
| FCF Yield | -72.64% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
KRX:950210 has an Altman Z-Score of -0.56 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.56 |
| Piotroski F-Score | 4 |